A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer
Developmental Cell · 2025
DOI: 10.1016/j.devcel.2025.11.005 ↗Kurz gefasst
Kommentar in der Zeitschrift Developmental Cell, 2025. Verfasst von Carmine Settembre. Beteiligte Einrichtung: Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy; Department of Clinical Medicine and Surgery, Federico II University, Naples, It…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Endoplasmic Reticulum, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 10 Literaturangaben. Gefördert von: European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. Electronic address: settembre@tigem.it.
Förderung
- European Research Council
Zitieren
APA
Settembre, C. (2025). A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.11.005
Vancouver
Settembre C. A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.11.005
BibTeX
@article{Settembre2025,
author = {Settembre, Carmine},
title = {A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer},
journal = {Developmental Cell},
year = {2025},
doi = {10.1016/j.devcel.2025.11.005}
}
EUVIMED